Diffusion of surgical innovation among patients with kidney cancer

Cancer

Volumn 112, Issue 8, 2008, Pages 1708-1717

  Miller, David C ^a   Saigal, Christopher S ^a,b   Banerjee, Mousumi ^c,d   Hanley, Jan ^b   Litwin, Mark S ^a,b,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RAND CORPORATION   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Kidney cancer; Laparoscopy; Partial nephrectomy; Practice patterns; Renal cell carcinoma; Surgery; Technology adoption

Indexed keywords

AGED; ARTICLE; CANCER STAGING; COMORBIDITY; DEMOGRAPHY; EARLY CANCER; ELDERLY CARE; FEMALE; HEALTH CARE QUALITY; HEMINEPHRECTOMY; HUMAN; INTERMETHOD COMPARISON; KIDNEY CANCER; KIDNEY SURGERY; LAPAROSCOPIC SURGERY; LAPAROSCOPY; MAJOR CLINICAL STUDY; MALE; MEDICARE; NEPHRECTOMY; OUTCOMES RESEARCH; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL RISK; SURGICAL TECHNIQUE; SURGICAL TRAINING; TUMOR VOLUME; UNINEPHRECTOMY;

AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIFFUSION OF INNOVATION; EDUCATIONAL STATUS; ETHNIC GROUPS; FEMALE; HUMANS; INCOME; KIDNEY NEOPLASMS; LAPAROSCOPY; MALE; MARITAL STATUS; MEDICARE; NEPHRECTOMY; NEPHRONS; PHYSICIAN'S PRACTICE PATTERNS; SEER PROGRAM; SEX FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 42149125509     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23372     Document Type: Article

References (55)

1. Novick AC. Laparoscopic and partial nephrectomy. Clin Cancer Res. 2004;10(18 pt 2):6322S-6327S.
2. Miller DC, Wei JT, Dunn RL, Hollenbeck BK. Trends in the diffusion of laparoscopic nephrectomy. JAMA. 2006;295:2480-2482.
3. Miller DC, Hollingsworth JM, Hafez KS, Daignault S, Hollenbeck BK. Partial nephrectomy for small renal masses: an emerging quality of care concern? J Urol. 2006;175:853-857.
4. Miller DC, Taub DA, Dunn RL, Wei JT, Hollenbeck BK. Laparoscopy for renal cell carcinoma: diffusion versus regionalization? J Urol. 2006;176:1102-1106.
5. Permpongkosol S, Bagga HS, Romero FR, Solomon SB, Kavoussi LR. Trends in the operative management of renal tumors over a 14-year period. BJU Int. 2006;98:751-755.
6. Bhayani SB, Belani JS, Hidalgo J, et al. Trends in nephron-sparing surgery for renal neoplasia. Urology. 2006;68:732-736.
7. Wolf JS, Merion RM, Leichtman AB, et al. Randomized controlled trial of hand-assisted laparoscopic versus open surgical live donor nephrectomy. Transplantation. 2001;72:284-290.
8. Simforoosh N, Basiri A, Tabibi A, Shakhssalim N, Hosseini Moghaddam SM. Comparison of laparoscopic and open donor nephrectomy: a randomized controlled trial. BJU Int. 2005;95:851-855.
9. Oyen O, Andersen M, Mathisen L, et al. Laparoscopic versus open living-donor nephrectomy: experiences from a prospective, randomized, single-center study focusing on donor safety. Transplantation. 2005;79:1236-1240.
10. Dunn MD, Portis AJ, Shalhav AL, et al. Laparoscopic versus open radical nephrectomy: a 9-year experience. J Urol. 2000;164:1153-1159.
11. Best S, Ercole B, Lee C, Fallon E, Skenazy J, Monga M. Minimally invasive therapy for renal cell carcinoma: is there a new community standard? Urology. 2004;64:22-25.
12. Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Wei JT. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology. 2006;67:254-259.
13. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year follow-up. J Urol. 2000;163:442-445.
14. Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol. 1999;162:1930-1933.
15. Lee CT, Katz J, Shi W, Thaler HT, Reuter VE, Russo P. Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol. 2000;163:730-736.
16. Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7:735-740.
17. Go AS, Chertow GM, Fan D, McCullogc CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351: 1296-1305.
18. Kutikov A, Fossett LK, Ramchandani P. Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology. 2006;68:737-740.
19. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98:1331-1334.
20. Subramanian S, Jones K, Duncan C. Multilevel methods for public health research. In: Kawachi I, Berkman L, eds. Neighborhoods and Health. New York, NY: Oxford University Press; 2003:65-111.
21. Snijders T, Bosker R. Multilevel Analysis. Thousand Oaks, Calif: SAGE Publications; 1999.
22. Hankey BF, Ries LA, Edwards BK. The Surveillance, Epidemiology, and End Results Program: a national resource. Cancer Epidemiol Biomarkers Prev. 1999;8:1117-1121.
23. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8 suppl):3-18.
24. Finlayson SR, Laycock WS, Birkmeyer JD. National trends in utilization and outcomes of antireflux surgery. Surg Endosc. 2003;17:864-867.
25. Bach PB, Guadagnoli E, Schrag D, Schussler N, Warren JL. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care. 2002;40(8 suppl):IV-19-IV-25.
26. Klabunde CN, Potosky AL, Legier JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53:1258-1267.
27. Klabunde CN, Harlan LC, Warren JL. Data sources for measuring comorbidity: a comparison of hospital records and Medicare claims for cancer patients. Med Care. 2006;44:921-928.
28. Russo P. Partial nephrectomy achieves local tumor control and prevents chronic kidney disease. Expert Rev Anticancer Ther. 2006;6:1745-1751.
29. Hollingsworth JM, Miller DC, Dunn RL, et al. Surgical management of low-stage renal cell carcinoma: technology does not supersede biology. Urology. 2006;67:1175-1180.
30. Bhayani SB, Clayman RV, Sundaram CP, et al. Surgical treatment of renal neoplasia: evolving toward a laparoscopic standard of care. Urology. 2003;62:821-826.
31. Scherr DS, Ng C, Munver R, Sosa RE, Vaughan ED, Del Pizzo J. Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: technology versus oncology. Urology. 2003;62:1007-1111.
32. Lotan Y, Duchene DA, Cadeddu JA, Sagalowsky AI, Koeneman KS. Changing management of organ-confined renal masses. J Endourol. 2004;18:263-268.
33. Baicker K, Chandra A, Skinner JS, Wennberg JE. Who you are and where you live: how race and geography affect the treatment of Medicare beneficiaries [supplemental Web exclusive]. Health Aff (Millwood). 2004;VAR:33-44.
34. Weinstein JN, Bronner KK, Morgan TS, Wennberg JE. Trends and geographic variations in major surgery for degenerative diseases of the hip, knee, and spine [supplemental Web exclusive]. Health Aff (Millwood). 2004; VAR: 81-89.
35. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist. J Natl Cancer Inst. 2006;98:839-845.
36. Hawley ST, Hofer TP, Janz NK, et al. Correlates of between-surgeon variation in breast cancer treatments. Med Care. 2006;44:609-616.
37. Aron M, Gill IS. Minimally invasive nephron-sparing surgery (MINSS) for renal tumours part II: probe ablative therapy. Eur Urol. 2007;51:348-357.
38. Kunkle DA, Crispen PL, Chen DY, Greenberg RE, Uzzo RG. Enhancing renal masses with zero net growth during active surveillance. J Urol. 2007;177:849-854.
39. Sachdeva AK. Acquiring skills in new procedures and technology: the challenge and the opportunity. Arch Surg. 2005;140:387-389.
40. Rogers EM. Diffusion of Innovations. New York, NY: Free Press; 2003.
41. McFall SL, Warnecke RB, Kaluzny AD, Ford SL. Practice setting and physician influences on judgments of colon cancer treatment by community physicians. Health Serv Res. 1996;31:5-19.
42. Escarce JJ. Externalities in hospitals and physician adoption of a new surgical technology: an exploratory analysis. J Health Econ. 1996;15:715-734.
43. Carroll PR, Albertsen PC, Smith JA, Howards SS. Volume of major surgeries performed by recent and more senior graduates from North American urology training programs. J Urol. 2006;175(suppl):1. Abstract 2.
44. Corica FA, Boker JR, Chou DS, et al. Short-term impact of a laparoscopic "mini-residency" experience on postgraduate urologists' practice patterns. J Am Coll Surg. 2006;203:692-698.
45. McDougall EM, Corica FA, Boker JR, et al. Construct validity testing of a laparoscopic surgical simulator. J Am Coll Surg. 2006;202:779-787.
46. Shalhav AL, Dabagia MD, Wagner TT, Koch MO, Lingeman JE. Training postgraduate urologists in laparoscopic surgery: the current challenge. J Urol. 2002;167:2135-2137.
47. Myers JA, Doolas A. How to teach an old dog new tricks and how to teach a new dog old tricks: bridging the generation gap to push the envelope of advanced laparoscopy. Surg Endosc. 2006;20:1177-1178.
48. Birkmeyer NJ, Birkmeyer JD. Strategies for improving surgical quality - should payers reward excellence or effort? N Engl J Med. 2006;354:864-870.
49. Gagliardi A, Ashbury FD, George R, Irish J, Stern HS. Improving cancer surgery in Ontario: recommendations from a strategic planning retreat. Can J Surg. 2004;47:270-276.
50. Wibe A, Moller B, Norstein J, et al. A national strategic change in treatment policy for rectal cancer - implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum. 2002;45:857-866.
51. Westfall JM, Mold J, Fagnan L. Practice-based research - "Blue Highways" on the NIH roadmap. JAMA. 2007;297:403-406.
52. Finlayson SR. Delivering quality to patients. JAMA. 2006;296:2026-2027.
53. Dimick JB, Finlayson SR, Birkmeyer JD. Regional availability of high-volume hospitals for major surgery [supplemental Web exclusive]. Health Aff (Millwood). 2004;VAR: 45-53.
54. Katz SJ, Hawley ST. From policy to patients and back: surgical treatment decision making for patients with breast cancer. Health Aff. 2007;26:761-769.
55. American College of Surgeons Commission on Cancer National Cancer Database. Public Access to Cancer Data: NCDB Public Benchmark Reports: diagnosis year, 2004; primary site, kidney/renal pelvis; variable 1, surgical procedure. Available at: http://web.facs.org/ncdbbmr/frames/public7/TABLES/ Y04S49XaTa_20000000_tb_B.html Accessed May 25, 2007.